146 related articles for article (PubMed ID: 9932729)
41. An antiplatelet peptide, gabonin, from Bitis gabonica snake venom.
Huang TF; Peng HC; Peng IS; Teng CM; Ouyang C
Arch Biochem Biophys; 1992 Oct; 298(1):13-20. PubMed ID: 1524422
[TBL] [Abstract][Full Text] [Related]
42. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles.
Teng CM; Yu SM; Ko FN; Chen CC; Wang WC; Chen KY; Huang YL; Huang TF
Eur J Pharmacol; 1991 Nov; 205(2):151-6. PubMed ID: 1812005
[TBL] [Abstract][Full Text] [Related]
43. Antithrombotic effects of a platelet fibrinogen receptor antagonist in a canine model of carotid artery thrombosis.
Willette RN; Sauermelch CF; Rycyna R; Sarkar S; Feuerstein GZ; Nichols AJ; Ohlstein EH
Stroke; 1992 May; 23(5):703-11. PubMed ID: 1605806
[TBL] [Abstract][Full Text] [Related]
44. Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation.
Fok KF; Panzer-Knodle SG; Nicholson NS; Tjoeng FS; Feigen LP; Adams SP
Int J Pept Protein Res; 1991 Aug; 38(2):124-30. PubMed ID: 1783488
[TBL] [Abstract][Full Text] [Related]
45. Effect of the platelet-activating factor antagonist BN 52021 on human natural killer cell cytotoxicity.
Mandi Y; Farkas G; Koltai M; Beladi I; Braquet P
Int Arch Allergy Appl Immunol; 1989; 88(1-2):222-4. PubMed ID: 2540096
[TBL] [Abstract][Full Text] [Related]
46. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
Braquet P; Hosford D; Koltz P; Guilbaud J; Paubert-Braquet M
Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
[TBL] [Abstract][Full Text] [Related]
47. Inhibitor(s) of platelet-activating factor (PAF) in human saliva.
Smal MA; Baldo BA
Lipids; 1991 Dec; 26(12):1144-7. PubMed ID: 1819702
[TBL] [Abstract][Full Text] [Related]
48. Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro.
Zhao L; Bath P; Heptinstall S
Br J Pharmacol; 2001 Sep; 134(2):353-8. PubMed ID: 11564653
[TBL] [Abstract][Full Text] [Related]
49. [Effect of cefaclor on guinea pig platelet aggregation in vitro].
Kakushi H; Shike T; Hayasaki Y; Matsubara T; Uchida K; Honma Y; Kawasumi K; Takeuchi Y
Nihon Yakurigaku Zasshi; 1990 Jun; 95(6):335-46. PubMed ID: 2379885
[TBL] [Abstract][Full Text] [Related]
50. PAF-acether in AK-5 tumour cells.
Marathe GK; Krishnakantha TP; D'Souza CJ
Cell Biol Int Rep; 1991 Jan; 15(1):85-90. PubMed ID: 2004428
[TBL] [Abstract][Full Text] [Related]
51. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series.
Weber KH; Heuer H
Int Arch Allergy Appl Immunol; 1989; 88(1-2):82-7. PubMed ID: 2540098
[TBL] [Abstract][Full Text] [Related]
52. Analogues of platelet activating factor. 7. Bis-aryl amide and bis-aryl urea receptor antagonists of PAF.
Wissner A; Carroll ML; Johnson BD; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Trova MP; Kohler CA
J Med Chem; 1992 Dec; 35(26):4779-89. PubMed ID: 1336052
[TBL] [Abstract][Full Text] [Related]
53. Sheep platelets as a model for human platelets: evidence for specific PAF (platelet activating factor) receptors.
Slattery CW; Beaumont DO
Thromb Res; 1989 Sep; 55(5):569-76. PubMed ID: 2554526
[TBL] [Abstract][Full Text] [Related]
54. Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion.
Alloatti G; Montrucchio G; Emanuelli G; Camussi G
J Mol Cell Cardiol; 1992 Feb; 24(2):163-71. PubMed ID: 1583699
[TBL] [Abstract][Full Text] [Related]
55. PAF receptor and "Cache-oreilles" effect. Simple PAF antagonists.
Lamotte-Brasseur J; Heymans F; Dive G; Lamouri A; Batt JP; Redeuilh C; Hosford D; Braquet P; Godfroid JJ
Lipids; 1991 Dec; 26(12):1167-71. PubMed ID: 1668113
[TBL] [Abstract][Full Text] [Related]
56. Xanthines inhibit human platelet aggregation induced by platelet-activating factor.
Misso NL; Thompson PJ
Clin Exp Pharmacol Physiol; 1992 Aug; 19(8):599-602. PubMed ID: 1526066
[TBL] [Abstract][Full Text] [Related]
57. Combined activation of platelets by cathepsin G and platelet activating factor, two neutrophil-derived agonists.
Renesto P; Kadiri C; Chignard M
Br J Haematol; 1992 Feb; 80(2):205-13. PubMed ID: 1550778
[TBL] [Abstract][Full Text] [Related]
58. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase.
Kuijpers TW; van den Berg JM; Tool AT; Roos D
Clin Exp Immunol; 2001 Mar; 123(3):412-20. PubMed ID: 11298128
[TBL] [Abstract][Full Text] [Related]
59. 1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
Cooper K; Fray MJ; Parry MJ; Richardson K; Steele J
J Med Chem; 1992 Aug; 35(17):3115-29. PubMed ID: 1507200
[TBL] [Abstract][Full Text] [Related]
60. Ginkgolides and platelet-activating factor binding sites.
Hosford DJ; Domingo MT; Chabrier PE; Braquet P
Methods Enzymol; 1990; 187():433-46. PubMed ID: 2172741
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
